Search results
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 7 hours agoThe review is now expected to be completed by the end of this month. The FDA has, however, not...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 3 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 3 days agoThe company said the FDA cited administrative constraints for the delay, and that the agency is working to complete its review of mRNA-1345 by the end of the month. Moderna
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 3 days agoThe FDA has informed Moderna that it is working to conclude...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 3 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 6 days agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 10 hours agoFortunately, there are good reasons to believe the company has what it takes. Moderna is inching...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 3 days agoThe Food and Drug Administration's move prolongs the wait for Moderna's second approved product, but...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 12 hours agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: